학술논문
Management of hypertension in pregnancy.
Document Type
Academic Journal
Author
Brown MA; Department of Renal Medicine, St George Hospital & University of NSW, Kogarah.; Whitworth JA
Source
Publisher: Informa Healthcare Country of Publication: England NLM ID: 9305929 Publication Model: Print Cited Medium: Print ISSN: 1064-1963 (Print) Linking ISSN: 10641963 NLM ISO Abbreviation: Clin Exp Hypertens Subsets: MEDLINE
Subject
Language
English
ISSN
1064-1963
Abstract
Hypertension in pregnancy is generally defined as either an absolute BP > 140/90 mm Hg or a rise in systolic BP > or = 25 mm Hg and/or diastolic BP > or = 15 mm Hg from pre-conception or 1st trimester BP. Hypertension in pregnancy is classified as: a) Chronic--essential or secondary hypertension, b) De novo--pre-eclampsia or gestational hypertension, and c) Pre-eclampsia superimposed on chronic hypertension. Pre-eclampsia is a multisystem disorder in which hypertension is but one sign. The major maternal abnormalities occur in kidneys, liver, brain and coagulation systems. Impaired uteroplacental blood flow causes fetal growth retardation or intrauterine death. There is general agreement that BP > or = 170/110 mm Hg should be lowered rapidly to protect the mother against risk of stroke or eclampsia. There is dispute concerning the level at which lesser degrees of hypertension should be treated, and lowering BP is treating only one aspect of pre-eclampsia. Delivery remains the definitive management.